PCI Biotech Holding ASA

    PCI Biotech Holding ASA

    OOSL:PCIB
    - -
    NOK
    - -
    - -
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    -1.97
    -2.14
    -3.22
    -2.12
    -2.01
    -1.76
    -1.25
    -3.19
    -1.94
    -2.37
    -1.48
    -0.54
    -0.44
    -0.78
    Free Cash Flow per Basic Share
    -1.9
    -2.22
    -2.85
    -2.18
    -2.22
    -1.26
    -1.45
    -2.94
    -2.08
    -1.83
    -1.58
    -0.4
    -0.37
    -0.81
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -7.87
    -2.58
    -6.08
    -5.08
    -6.7
    -4.74
    -3.94
    -7.03
    -7.01
    -9.02
    1.54
    0.03
    0.03
    3
    Tangible Book Value per Share
    5.43
    3.36
    0.82
    2.94
    0.82
    1.72
    12.23
    9.17
    5.08
    3.05
    1.54
    1.04
    0.63
    1.26
    Basic Weighted Avg Shares
    13
    13
    11
    15
    16
    24
    28
    28
    37
    37
    37
    38
    37
    37
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    2
    3
    6
    - -
    - -
    1
    Net Income, GAAP
    -25
    -28
    -36
    -32
    -32
    -43
    -35
    -89
    -72
    -88
    -55
    -20
    -16
    -29
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    71
    43
    9
    44
    13
    44
    340
    251
    181
    107
    57
    39
    23
    47
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    1
    - -
    - -
    - -
    - -
    Total Equity
    70
    43
    9
    44
    13
    42
    340
    255
    189
    114
    57
    39
    23
    47
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -69.43
    -1,467.11
    -8.63

    Capital Structure

    NOK

    •

    in mil. unless spec.
    Dec'22
    Mar'23
    Jun'23
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    37
    37
    37
    Market Capitalization
    77
    77
    79

    Working Capital

    NOK

    •

    in mil. unless spec.
    Dec'22
    Mar'23
    Jun'23
    Total Current Assets
    63
    57
    52
    Cash, Cash Equivalents & STI
    56
    51
    46
    Accounts Receivable, Net
    - -
    6
    6
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    6
    5
    5
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    NOK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    103.56%
    -37.41%
    -39.93%
    Free Cash Flow
    1.94%
    -22.66%
    -8.1%
    Net Income, GAAP
    4.31%
    -23.25%
    -19.19%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    NOK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    NOK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.16
    -0.15
    - -
    - -
    -0.54
    2024
    - -
    - -
    - -
    - -
    -0.44
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    NOK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business